SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-042624
Filing Date
2018-02-13
Accepted
2018-02-13 16:31:13
Documents
6
Period of Report
2018-02-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d516609d8k.htm 8-K 21652
2 EX-1.1 d516609dex11.htm EX-1.1 148627
3 EX-4.1 d516609dex41.htm EX-4.1 159119
4 EX-5.1 d516609dex51.htm EX-5.1 11182
5 EX-99.1 d516609dex991.htm EX-99.1 7548
6 GRAPHIC g516609g46q13.jpg GRAPHIC 5463
  Complete submission text file 0001193125-18-042624.txt   357178
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-769-9145
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36395 | Film No.: 18603894
SIC: 2834 Pharmaceutical Preparations